Transcriptional regulatory elements in the human genome

Annual Review of Genomics and Human Genetics

Volumn 7, Issue , 2006, Pages 29-59

  Maston, Glenn A ^a   Evans, Sara K ^a   Green, Michael R ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Bioinformatics; Functional genomics; Transcription factors

Indexed keywords

BINDING PROTEIN; DEOXYRIBONUCLEOPROTEIN; DINUCLEOTIDE; REGULATOR PROTEIN; RNA POLYMERASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 1;

BIOINFORMATICS; CHROMATIN IMMUNOPRECIPITATION; COMPARATIVE GENOMIC HYBRIDIZATION; CPG ISLAND; DNA FOOTPRINTING; DNA METHYLATION; DNA RESPONSIVE ELEMENT; ENHANCER REGION; FUNCTIONAL GENOMICS; GENE ACTIVATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE LOCUS; GENE SILENCING; GENETIC DISORDER; HUMAN; HUMAN GENOME; INSULATOR ELEMENT; MICROARRAY ANALYSIS; MOLECULAR BIOLOGY; MOLECULAR RECOGNITION; NONHUMAN; PHYLOGENY; PROMOTER REGION; REGULATORY MECHANISM; REVIEW; SILENCER ELEMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TATA BOX; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION;

GENE EXPRESSION REGULATION; GENOME, HUMAN; HUMANS; REGULATORY ELEMENTS, TRANSCRIPTIONAL; TRANSCRIPTION FACTORS;

EID: 33750352462     PISSN: 15278204     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.genom.7.080505.115623     Document Type: Review

References (216)

1. Adlam M, Siu G. 2003. Hierarchical interactions control CD4 gene expression during thymocyte development. Immunity 18:173-84
2. Altshuler D, Brooks LD, Chakravarti A, Collins FS, Daly MJ, et al. 2005. A haplotype map of the human genome. Nature 437:1299-320
3. Amiel J, Laudier B, Attie-Bitach T, Trang H, de Pontual L, et al. 2003. Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat. Genet. 33:459-61
4. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. 1999. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23:185-88
5. Antonarakis SE, Irkin SH, Cheng TC, Scott AF, Sexton JP, et al. 1984. β-Thalassemia in American Blacks: novel mutations in the "TATA" box and an acceptor splice site. Proc. Natl. Acad. Sci. USA 81:1154-58
6. Aronow BJ, Silbiger RN, Dusing MR, Stock JL, Yager KL, et al. 1992. Functional analysis of the human adenosine deaminase gene thymic regulatory region and its ability to generate position-independent transgene expression. Mol. Cell. Biol. 12:4170-85
7. Ashurst JL, Collins JE. 2003. Gene annotation: prediction and testing. Annu. Rev. Genomics Hum. Genet. 4:69-88
8. Atchison ML. 1988. Enhancers: mechanisms of action and cell specificity. Annu. Rev. Cell. Biol. 4:127-53
9. Bailey TL, Elkan C. 1995. The value of prior knowledge in discovering motifs with MEME. Proc. Int. Conf. Intell. Syst. Mol. Biol. 3:21-29
10. Bajic VB, Tan SL, Suzuki Y, Sugano S. 2004. Promoter prediction analysis on the whole human genome. Nat. Biotechnol. 22:1467-73
11. Balhoff JP, Wray GA. 2005. Evolutionary analysis of the well characterized endo16 promoter reveals substantial variation within functional sites. Proc. Natl. Acad. Sci. USA 102:8591-96
12. Banerjee S, Smallwood A, Lamond S, Campbell S, Nargund G. 2001. Igf2/H19 imprinting control region (ICR): an insulator or a position-dependent silencer? Sci. World J. 1:218-24
13. Banerji J, Olson L, Schaffner W. 1983. A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes. Cell 33:729-40
14. Banerji J, Rusconi S, Schaffner W. 1981. Expression of a β-globin gene is enhanced by remote SV40 DNA sequences. Cell 27:299-308
15. Banine F, Bartlett C, Gunawardena R, Muchardt C, Yaniv M, et al. 2005. SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation. Cancer Res. 65:3542-47
16. Bank A. 2006. Regulation of human fetal hemoglobin: new players, new complexities. Blood 107:435-43
17. Bell AC, Felsenfeld G. 2000. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 405:482-85
18. Bell AC, West AG, Felsenfeld G. 1999. The protein CTCF is required for the enhancer blocking activity of vertebrate insulators. Cell 98:387-96
19. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, et al. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27:20-21
20. Bird A. 1987. CpG islands as gene markers in the vertebrate nucleus. Trends Genet. 3:342-47
21. Blackwood EM, Kadonaga JT. 1998. Going the distance: a current view of enhancer action. Science 281:60-63
22. Blanchette M, Tompa M. 2003. FootPrinten a program designed for phylogenetic footprinting. Nucleic Acids Res. 31:3840-42
23. Boffelli D, McAuliffe J, Ovcharenko D, Lewis KD, Ovcharenko I, et al. 2003. Phylogenetic shadowing of primate sequences to find functional regions of the human genome. Science 299:1391-94
24. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, et al. 2003. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299:256-59
25. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, et al. 2005. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122:947-56
26. Buckland PR, Hoogendoorn B, Coleman SL, Guy CA, Smith SK, O'Donovan MC. 2005. Strong bias in the location of functional promoter polymorphisms. Hum. Mutat. 26:214-23
27. Burgess-Beusse B, Farrell C, Gaszner M, Litt M, Mutskov V, et al. 2002. The insulation of genes from external enhancers and silencing chromatin. Proc. Natl. Acad. Sci. USA 99:16433-37
28. Cameron RA, Chow SH, Berney K, Chiu TY, Yuan QA, et al. 2005. An evolutionary constraint: strongly disfavored class of change in DNA sequence during divergence of cis-regulatory modules. Proc. Natl. Acad. Sci. USA 102:11769-74
29. Cantor AB. 2005. GATA transcription factors in hematologic disease. Int. J. Hematol. 81:378-84
30. Capelson M, Corces VG. 2004. Boundary elements and nuclear organization. Biol. Cell 96:617-29
31. Carey M, Lin YS, Green MR, Ptashne M. 1990. A mechanism for synergistic activation of a mammalian gene by GAL4 derivatives. Nature 345:361-64
32. Carey M, Smale ST. 2000. Transcriptional Regulation in Eukaryotes: Concepts, Strategies, and Techniques. Cold Spring Harbor, NY: Cold Spring Harbor Lab. Press
33. Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, et al. 2005. The transcriptional landscape of the mammalian genome. Science 309:1559-63
34. Cavin Perier R, Junier T, Bucher P. 1998. The Eukaryotic Promoter Database EPD. Nucleic Acids Res 26:353-57
35. Cawley S, Bekiranov S, Ng HH, Kapranov P, Sekinger EA, et al. 2004. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116:499-509
36. Chakalova L, Carter D, Debrand E, Goyenechea B, Horton A, et al. 2005. Developmental regulation of the β-globin gene locus. Prog. Mol. Subcell. Biol. 38:183-206
37. Chen L, Widom J. 2005. Mechanism of transcriptional silencing in yeast. Cell 120:37-48
38. Chen Z, Manley JL. 2003. Core promoter elements and TAFs contribute to the diversity of transcriptional activation in vertebrates. Mol. Cell. Biol. 23:7350-62
39. Claessens F, Gewirth DT. 2004. DNA recognition by nuclear receptors. Essays Biochem. 40:59-72
40. Conaway JW, Florens L, Sato S, Tomomori-Sato C, Parmely TJ, et al. 2005. The mammalian Mediator complex. FEBS Lett 579:904-8
41. Consortium IHGS. 2004. Finishing the euchromatic sequence of the human genome. Nature 411:911-45
42. Cook PR. 2003. Nongenic transcription, gene regulation and action at a distance. J. Cell. Sci. 116:4483-91
43. Cooper GM, Stone EA, Asimenos G, Green ED, Batzoglou S, Sidow A. 2005. Distribution and intensity of constraint in mammalian genomic sequence. Genome Res. 15:901-13
44. Crawford GE, Holt IE, Mullikin JC, Tai D, Blakesley R, et al. 2004. Identifying gene regulatory elements by genome-wide recovery of DNase hypersensitive sites. Proc. Natl. Acad. Sci. USA 101:992-97
45. Crossley M, Brownlee GG. 1990. Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia B. Nature 345:444-46
46. Davuluri RV, Grosse I, Zhang MQ. 2001. Computational identification of promoters and first exons in the human genome. Nat. Genet. 29:412-17
47. de Kok YJ, van der Maarel SM, Bitner-Glindzicz M, Huber I, Monaco AP, et al. 1995. Association between X-linked mixed deafness and mutations in the POU domain gene POU3F4. Science 267:685-88
48. de Kok YJ, Vossenaar ER, Cremers CW, Dahl N, Laporte J, et al. 1996. Identification of a hot spot for microdeletions in patients with X-linked deafness type 3 (DFN3) 900 kb proximal to the DFN3 gene POU3F4. Hum. Mol. Genet. 5:1229-35
49. de la Serna IL, Ohkawa Y, Berkes CA, Bergstrom DA, Dacwag CS, et al. 2005. MyoD targets chromatin remodeling complexes to the myogenin locus prior to forming a stable DNA-bound complex. Mol. Cell. Biol. 25:3997-4009
50. Defossez PA, Kelly KF, Filion GJ, Perez-Torrado R, Magdinier F, et al. 2005. The human enhancer blocker CTC-binding factor interacts with the transcription factor Kaiso. J. Biol. Chem. 280:43017-23
51. Dermitzakis ET, Clark AG. 2002. Evolution of transcription factor binding sites in Mammalian gene regulatory regions: conservation and turnover. Mol. Biol. Evol. 19:1114-21
52. Dike S, Balija VS, Nascimento LU, Xuan Z, Ou J, et al. 2004. The mouse genome: experimental examination of gene predictions and transcriptional start sites. Genome Res. 14:2424-29
53. Down TA, Hubbard TJ. 2002. Computational detection and location of transcription start sites in mammalian genomic DNA. Genome Res. 12:458-61
54. Driscoll MC, Dobkin CS, Alter BP. 1989. Gamma Δ β-thalassemia due to a de novo mutation deleting the 5′ β-globin gene activation-region hypersensitive sites. Proc. Natl. Acad. Sci. USA 86:7470-74
55. Ek J, Andersen G, Urhammer SA, Gaede PH, Drivsholm T, et al. 2001. Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus. Diabetologia 44:2220-26
56. Ellingsen S, Laplante MA, Konig M, Kikuta H, Furmanek T, et al. 2005. Large-scale enhancer detection in the zebrafish genome. Development 132:3799-811
57. Esteller M. 2005. DNA methylation and cancer therapy: new developments and expectations. Curr. Opin. Oncol. 17:55-60
58. Euskirchen G, Royce TE, Bertone P, Martone R, Rinn JL, et al. 2004. CREB binds to multiple loci on human chromosome 22. Mol. Cell. Biol. 24:3804-14
59. Felsenfeld G, Burgess-Beusse B, Farrell C, Gaszner M, Ghirlando R, et al. 2004. Chromatin boundaries and chromatin domains. Cold. Spring Harb. Symp. Quant. Biol. 69:245-50
60. Fickett JW, Hatzigeorgiou AG. 1997. Eukaryotic promoter recognition. Genome Res. 7:861-78
61. Florquin K, Saeys Y, Degroeve S, Rouze P, Van de Peer Y. 2005. Large-scale structural analysis of the core promoter in mammalian and plant genomes. Nucleic Acids Res. 33:4255-64
62. Fogel GB, Weekes DG, Varga G, Dow ER, Craven AM, et al. 2005. A statistical analysis of the TRANSFAC database. Biosystems 81:137-54
63. Follows GA, Tagoh H, Lefevre P, Morgan GJ, Bonifer C. 2003. Differential transcription factor occupancy but evolutionarily conserved chromatin features at the human and mouse M-CSF (CSF-1) receptor loci. Nucleic Acids Res. 31:5805-16
64. Forget BG. 1998. Molecular basis of hereditary persistence of fetal hemoglobin. Ann. N. Y. Acad. Sci. 850:38-44
65. Foster JW, Dominguez-Steglich MA, Guioli S, Kowk G, Weller PA, et al. 1994. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372:525-30
66. Fourel G, Magdinier F, Gilson E. 2004. Insulator dynamics and the setting of chromatin domains. Bioessays 26:523-32
67. Freson K, Devriendt K, Matthijs G, Van Hoof A, De Vos R, et al. 2001. Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation. Blood 98:85-92
68. Gabellini D, Green MR, Tupler R. 2002. Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell 110:339-48
69. Gardiner-Garden M, Frommer M. 1987. CpG islands in vertebrate genomes. J. Mol. Biol. 196:261-82
70. Gershenzon NI, Ioshikhes IP. 2005. Synergy of human Pol II core promoter elements revealed by statistical sequence analysis. Bioinformatics 21:1295-300
71. Geserick C, Meyer HA, Haendler B. 2005. The role of DNA response elements as allosteric modulators of steroid receptor function. Mol. Cell. Endocrinol. 236:1-7
72. Gibbons RJ, Picketts DJ, Villard L, Higgs DR. 1995. Mutations in a putative global transcriptional regulator cause X-linked mental retardation with α-thalassemia (ATR-X syndrome). Cell 80:837-45
73. Gowri PM, Yu JH, Shaufl A, Sperling MA, Menon RK. 2003. Recruitment of a repressosome complex at the growth hormone receptor promoter and its potential role in diabetic nephropathy. Mol. Cell. Biol. 23:815-25
74. Green MR. 2005. Eukaryotic transcription activation: right on target. Mol. Cell 18:399-402
75. Gross DS, Garrard WT. 1988. Nuclease hypersensitive sites in chromatin. Annu. Rev. Biochem. 57:159-97
76. Grosveld F, van Assendelft GB, Greaves DR, Kollias G. 1987. Position-independent, high-level expression of the human β-globin gene in transgenic mice. Cell 51:975-85
77. Hahn S. 2004. Structure and mechanism of the RNA polymerase II transcription machinery. Nat. Struct. Mol. Biol. 11:394-403
78. Harris MB, Mostecki J, Rothman PB. 2005. Repression of an interleukin-4-responsive promoter requires cooperative BCL-6 function. J. Biol. Chem. 280:13114-21
79. Hatton CS, Wilkie AO, Drysdale HC, Wood WG, Vickers MA, et al. 1990. α-thalassemia caused by a large (62 kb) deletion upstream of the human α globin gene cluster. Blood 76:221-27
80. Hersh BM, Carroll SB. 2005. Direct regulation of knot gene expression by Ultrabithorax and the evolution of cis-regulatory elements in Drosophila. Development 132:1567-77
81. Hitzler JK, Zipursky A. 2005. Origins of leukaemia in children with Down syndrome. Nat. Rev. Cancer 5:11-20
82. Hobbs K, Negri J, Klinnert M, Rosenwasser LJ, Borish L. 1998. Interleukin-10 and transforming growth factor-β promoter polymorphisms in allergies and asthma. Am. J. Respir. Crit. Care Med. 158:1958-62
83. Hoogendoorn B, Coleman SL, Guy CA, Smith K, Bowen T, et al. 2003. Functional analysis of human promoter polymorphisms. Hum. Mol. Genet. 12:2249-54
84. Horak CE, Mahajan MC, Luscombe NM, Gerstein M, Weissman SM, Snyder M. 2002. GATA-1 binding sites mapped in the β-globin locus by using mammalian chip-chip analysis. Proc. Natl. Acad. Sci. USA 99:2924-29
85. Hughes JD, Estep PW, Tavazoie S, Church GM. 2000. Computational identification of cis-regulatory elements associated with groups of functionally related genes in Saccharomyces cerevisiae. J. Mol. Biol. 296:1205-14
86. Huttenhofer A, Schattner P, Polacek N. 2005. Non-coding RNAs: hope or hype? Trends Genet. 21:289-97
87. Ioshikhes IP, Zhang MQ. 2000. Large-scale human promoter mapping using CpG islands. Nat. Genet. 26:61-63
88. Jiang J, Levine M. 1993. Binding affinities and cooperative interactions with bHLH activators delimit threshold responses to the dorsal gradient morphogen. Cell 72:741-52
89. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, et al. 1998. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 19:187-91
90. Jordan T, Hanson I, Zaletayev D, Hodgson S, Prosser J, et al. 1992. The human PAX6 gene is mutated in two patients with aniridia. Nat. Genet. 1:328-32
91. Kadonaga JT. 2004. Regulation of RNA polymerase II transcription by sequence-specific DNA binding factors. Cell 116:247-57
92. Kel AE, Gossling E, Reuter I, Cheremushkin E, Kel-Margoulis OV, Wingender E. 2003. MATCH: a tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res. 31:3576-79
93. Kim TH, Barrera LO, Qu C, Van Calcar S, Trinklein ND, et al. 2005. Direct isolation and identification of promoters in the human genome. Genome Res. 15:830-39
94. King DC, Taylor J, Elnitski L, Chiaromonte F, Miller W, Hardison RC. 2005. Evaluation of regulatory potential and conservation scores for detecting cis-regulatory modules in aligned mammalian genome sequences. Genome Res. 15:1051-60
95. Klug A. 2005. Towards therapeutic applications of engineered zinc finger proteins. FEBS Lett. 579:892-94
96. Koivisto UM, Palvimo JJ, Janne OA, Kontula K. 1994. A single-base substitution in the proximal Sp1 site of the human low density lipoprotein receptor promoter as a cause of heterozygous familial hypercholesterolemia. Proc. Natl. Acad. Sci. USA 91:10526-30
97. Kulkarni MM, Arnosti DN. 2005. cis-regulatory logic of short-range transcriptional repression in Drosophila melanogaster. Mol. Cell. Biol. 25:3411-20
98. Kulozik AE, Bellan-Koch A, Bail S, Kohne E, Kleihauer E. 1991. Thalassemia intermedia: moderate reduction of β-globin gene transcriptional activity by a novel mutation of the proximal CACCC promoter element. Blood 77:2054-58
99. Lalioti MD, Scott HS, Antonarakis SE. 1999. Altered spacing of promoter elements due to the dodecamer repeat expansion contributes to reduced expression of the cystatin B gene in EPM1. Hum. Mol. Genet. 8:1791-98
100. Lalioti MD, Scott HS, Buresi C, Rossier C, Bottani A, et al. 1997. Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy. Nature 386:847-51
101. Lang G, Mamalaki C, Greenberg D, Yannoutsos N, Kioussis D. 1991. Deletion analysis of the human CD2 gene locus control region in transgenic mice. Nucleic Acids Res. 19:5851-56
102. LeBrun DP. 2003. E2A basic helix-loop-helix transcription factors in human leukemia. Front. Biosci. 8:206-22
103. Lee B, Vouthounis C, Stojadinovic O, Brem H, Im M, Tomic-Canic M. 2005. From an enhanceosome to a repressosome: Molecular antagonism between glucocorticoids and EGF leads to inhibition of wound healing. J. Mol. Biol. 345:1083-97
104. Lee DH, Gershenzon N, Gupta M, Ioshikhes IP, Reinberg D, Lewis BA. 2005. Functional characterization of core promoter elements: the downstream core element is recognized by TAF1. Mol. Cell. Biol. 25:9674-86
105. Lee GR, Fields PE, Griffin TJ, Flavell RA. 2003. Regulation of the Th2 cytokine locus by a locus control region. Immunity 19:145-53
106. Lee MP, Howcroft K, Kotekar A, Yang HH, Buetow KH, Singer DS. 2005. ATG deserts define a novel core promoter subclass. Genome Res. 15:1189-97
107. Lee TI, Young RA. 2000. Transcription of eukaryotic protein-coding genes. Annu. Rev. Genet. 34:77-137
108. Lefstin JA, Yamamoto KR. 1998. Allosteric effects of DNA on transcriptional regulators. Nature 392:885-88
109. Lehmann AR. 2001. The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases. Genes Dev. 15:15-23
110. Lemon B, Tjian R. 2000. Orchestrated response: a symphony of transcription factors for gene control. Genes Dev. 14:2551-69
111. Lettice LA, Heaney SJ, Purdie LA, Li L, de Beer P, et al. 2003. A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. Hum. Mol. Genet. 12:1725-35
112. Leung TH, Hoffmann A, Baltimore D. 2004. One nucleotide in a kappaB site can determine cofactor specificity for NF-kappaB dimers. Cell 118:453-64
113. Lewis BA, Kim TK, Orkin SH. 2000. A downstream element in the human β-globin promoter: evidence of extended sequence-specific transcription factor UD contacts. Proc. Natl. Acad. Sci. USA 97:7172-77
114. Li L, He S, Sun JM, Davie JR. 2004. Gene regulation by Sp1 and Sp3. Biochem. Cell. Biol. 82:460-71
115. Li Q, Peterson KR, Fang X, Stamatoyannopoulos G. 2002. Locus control regions. Blood 100:3077-86
116. Li Q, Zhang M, Duan Z, Stamatoyannopoulos G. 1999. Structural analysis and mapping of DNase I hypersensitivity of HS5 of the β-globin locus control region. Genomics 61:183-93.
117. Lim CY, Santoso B, Boulay T, Dong E, Ohler U, Kadonaga JT. 2004. The MTE, a new core promoter element for transcription by RNA polymerase II. Genes Dev. 18:1606-17
118. Lin YS, Carey M, Ptashne M, Green MR. 1990. How different eukaryotic transcriptional activators can cooperate promiscuously. Nature 345:359-61
119. Lonard DM, O'Malley BW. 2005. Expanding functional diversity of the coactivators. Trends Biochem. Sci. 30:126-32
120. Loots GG, Kneissel M, Keller H, Baptist M, Chang J, et al. 2005. Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease. Genome Res. 15:928-35
121. Ludlow LB, Schick BP, Budarf ML, Driscoll DA, Zackai EH, et al. 1996. Identification of a mutation in a GATA binding site of the platelet glycoprotein Ibβ promoter resulting in the Bernard-Soulier syndrome. J. Biol. Chem. 271:22076-80
122. Ludwig MZ, Bergman C, Patel Nil, Kreitman M. 2000. Evidence for stabilizing selection in a eukaryotic enhancer element. Nature 403:564-67
123. Malik S, Roeder RG. 2005. Dynamic regulation of pol II transcription by the mammalian Mediator complex. Trends Biochem. Sci. 30:256-63
124. Manco L, Ribeiro ML, Maximo V, Almeida H, Costa A, et al. 2000. A new PKLR gene mutation in the R-type promoter region affects the gene transcription causing pyruvate kinase deficiency. Br. J. Haematol. 110:993-97
125. Martin N, Patel S, Segre JA. 2004. Long-range comparison of human and mouse Sprr loci to identify conserved noncoding sequences involved in coordinate regulation. Genome Res. 14:2430-38
126. Martone R, Euskirchen G, Bertone P, Hartman S, Royce TE, et al. 2003. Distribution of NF-kappaB-binding sites across human chromosome 22. Proc. Natl. Acad. Sci. USA 100:12247-52
127. Masotti C, Armelin-Correa LM, Splendore A, Lin CJ, Barbosa A, et al. 2005. A functional SNP in the promoter region of TCOF1 is associated with reduced gene expression and YY1 DNA-protein interaction. Gene 359:44-52
128. Massari ME, Murre C. 2000. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol. Cell. Biol. 20:429-40
129. Matsuda M, Sakamoto N, Fukumaki Y. 1992. Δ-thalassemia caused by disruption of the site for an erythroid-specific transcription factor, GATA-1, in the Δ-globin gene promoter. Blood 80:1347-51
130. McKnight SL, Kingsbury R. 1982. Transcriptional control signals of a eukaryotic protein-coding gene. Science 217:316-24
131. Mehaffey MG, Newton AL, Gandhi MJ, Crossley M, Drachman JG. 2001. X-linked thrombocytopenia caused by a novel mutation of GATA-1. Blood 98:2681-88
132. Merika M, Williams AJ, Chen G, Collins T, Thanos D. 1998. Recruitment of CBP/p300 by the IFN β enhanceosome is required for synergistic activation of transcription. Mol. Cell. 1:277-87
133. Miller W, Makova KD, Nekrutenko A, Hardison RC. 2004. Comparative genomics. Annu. Rev. Genomics Hum. Genet. 5:15-56
134. Moi P, Faa V, Marini MG, Asunis I, Ibba G, et al. 2004. A novel silent β-thalassemia mutation in the distal CACCC box affects the binding and responsiveness to EKLF. Br. J. Haematol. 126:881-84
135. Mooney S. 2005. Bioinformatics approaches and resources for single nucleotide polymorphism functional analysis. Brief. Bioinform. 6:44-56
136. Morris JR, Petrov DA, Lee AM, Wu CT. 2004. Enhancer choice in cis and in trans in Drosophila melanogaster: role of the promoter. Genetics 167:1739-47
137. Muller F, Tora L. 2004. The multicoloured world of promoter recognition complexes. EMBO J. 23:2-8
138. Muller F, Williams DW, Kobolak J, Gauvry L, Goldspink G, et al. 1997. Activator effect of coinjected enhancers on the muscle-specific expression of promoters in zebrafish embryos. Mol. Reprod. Dev. 47:404-12
139. Murata T, Kurokawa R, Krones A, Tatsumi K, Ishii M, et al. 2001. Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome. Hum. Mol. Genet. 10:1071-76
140. Murayama A, Kim MS, Yanagisawa J, Takeyama K, Kato S. 2004. Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching. EMBO J. 23:1598-608
141. Naar AM, Lemon BD, Tjian R. 2001. Transcriptional coactivator complexes. Annu. Rev. Biochem. 70:475-501
142. Nichols KE, Crispino JD, Poncz M, White JG, Orkin SH, et al. 2000. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat. Genet. 24:266-70
143. Nobrega MA, Ovcharenko I, Afzal V, Rubin EM. 2003. Scanning human gene deserts for long-range enhancers. Science 302:413
144. Ogbourne S, Antalis TM. 1998. Transcriptional control and the role of silencers in transcriptional regulation in eukaryotes. Biochem. J. 331(Pt. 1):1-14
145. Orphanides G, Lagrange T, Reinberg D. 1996. The general transcription factors of RNA polymerase II. Genes Dev. 10:2657-83
146. Pabo CO, Sauer RT. 1992. Transcription factors: structural families and principles of DNA recognition. Annu. Rev. Biochem. 61:1053-95
147. Palhan VB, Chen S, Peng GH, Tjernberg A, Gamper AM, et al. 2005. Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration. Proc. Natl. Acad. Sci. USA 102:8472-77
148. Papatsenko D, Levine M. 2005. Quantitative analysis of binding motifs mediating diverse spatial readouts of the Dorsal gradient in the Drosophila embryo. Proc. Natl. Acad. Sci. USA 102:4966-71
149. Perissi V, Aggarwal A, Glass CK, Rose DW, Rosenfeld MG. 2004. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116:511-26
150. Popescu NC, Zimonjic DB. 2002. Chromosome-mediated alterations of the MYC gene in human cancer. J. Cell. Mol. Med. 6:151-59
151. Prawitt D, Enklaar T, Gartner-Rupprecht B, Spangenberg C, Oswald M, et al. 2005. Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor. Proc. Natl. Acad. Sci. USA 102:4085-90
152. Privalsky ML. 2004. The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annu. Rev. Physiol. 66:315-60
153. Ptashne M, Gann A. 1997. Transcriptional activation by recruitment. Nature 386:569-77
154. Quandt K, Frech K, Karas H, Wingender E, Werner T. 1995. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23:4878-84
155. Rebar EJ. 2004. Development of pro-angiogenic engineered transcription factors for the treatment of cardiovascular disease. Exp. Opin. Investig. Drugs 13:829-39
156. Recillas-Targa F, Pikaart MJ, Burgess-Beusse B, Bell AC, Litt MD, et al. 2002. Position-effect protection and enhancer blocking by the chicken β-globin insulator are separable activities. Proc. Natl. Acad. Sci. USA 99:6883-88
157. Recillas-Targa F, Valadex-Graham V, Farrell CM. 2004. Prospects and implications of using chromatin insulators in gene therapy and transgenesis. Bioessays 26:796-807
158. Remenyi A, Scholer HR, Wilmanns M. 2004. Combinatorial control of gene expression. Nat. Struct. Mol. Biol. 11:812-15
159. Ren B, Robert F, Wyrick JJ, Aparicio O, Jennings EG, et al. 2000. Genome-wide location and function of DNA binding proteins. Science 290:2306-9
160. Rockman MV, Wray GA. 2002. Abundant raw material for cis-regulatory evolution in humans. Mol. Biol. Evol. 19:1991-2004
161. Saglio G, Cilloni D. 2004. Abl: the prototype of oncogenic fusion proteins. Cell. Mol. Life Sci. 61:2 897-911
162. Sandelin A, Alkema W, Engstrom P, Wasserman WW, Lenhard B. 2004. JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res. 32:D91-94
163. Schaffner G, Schirm S, Muller-Baden B, Weber F, Schaffner W. 1988. Redundancy of information in enhancers as a principle of mammalian transcription control. J. Mol. Biol. 201:81-90
164. Scherf M, Klingenhoff A, Werner T. 2000. Highly specific localization of promoter regions in large genomic sequences by PromoterInspector: a novel context analysis approach. J. Mol. Biol. 297:599-606
165. Schmitt S, Prestel M, Paro R. 2005. Intergenic transcription through a polycomb group response element counteracts silencing. Genes Dev. 19:697-708
166. Schott JJ, Benson DW, Basson CT, Pease W, Silberbach GM, et al. 1998. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 281:108-11
167. Scully KM, Jacobson EM, Jepsen K, Lunyak V, Viadiu H, et al. 2000. Allosteric effects of Pit-1 DNA sites on long-term repression in cell type specification. Science 290:1127-31
168. Sertil O, Kapoor R, Cohen BD, Abramova N, Lowry CV. 2003. Synergistic repression of anaerobic genes by Mot3 and Rox1 in Saccharomyces cerevisiae. Nucleic Acids Res. 31:5831-37
169. Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, et al. 2005. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res. 15:1034-50
170. Smale ST, Kadonaga JT. 2003. The RNA polymerase II core promoter. Annu. Rev. Biochem. 72:449-79
171. Solis C, Aizencang GI, Astrin KH, Bishop DF, Desnick RJ. 2001. Uroporphyrinogen III synthase erythroid promoter mutations in adjacent GATA1 and CP2 elements cause congenital erythropoietic porphyria. J. Clin. Invest. 107:753-62
172. Spiegelman BM, Heinrich R. 2004. Biological control through regulated transcriptional coactivators. Cell 119:157-67
173. Spilianakis CG, Lalioti MD, Town T, Lee GR, Flavell RA. 2005. Interchromosomal associations between alternatively expressed loci. Nature 435:637-45
174. Srinivasan L, Atchison ML. 2004. YY1 DNA binding and PcG recruitment requires CtBP. Genes Dev. 18:2596-601
175. Stone EA, Cooper GM, Sidow A. 2005. Trade-offs in detecting evolutionarily constrained sequence by comparative genomics. Annu. Rev. Genomics Hum. Genet, 6:143-64
176. Stormo GD. 2000. DNA binding sites: representation and discovery. Bioinformatics 16:16-23
177. Sun X, Frierson HF, Chen C, Li C, Ran Q, et al. 2005. Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer. Nat. Genet. 37:407-12
178. Suzuki Y, Yamashita R, Nakai K, Sugano S. 2002. DBTSS: DataBase of human Transcriptional Start Sites and full-length cDNAs. Nucleic Acids Res. 30:328-31
179. Szutorisz H, Dillon N, Tora L. 2005. The role of enhancers as centres for general transcription factor recruitment. Trends Biochem. Sci. 30:593-99
180. Tagle DA, Koop BF, Goodman M, Slightom JL, Hess DL, Jones RT. 1988. Embryonic epsilon and gamma globin genes of a prosimian primate (Galago crassicaudatus). Nucleotide and amino acid sequences, developmental regulation and phylogenetic footprints. J. Mol. Biol. 203:439-55
181. Tanimoto K, Liu Q, Bungert J, Engel JD. 1999. Effects of altered gene order or orientation of the locus control region on human β-globin gene expression in mice. Nature 398:344-48
182. Thanos D, Maniatis T. 1995. Virus induction of human IFN β gene expression requires the assembly of an enhanceosome. Cell 83:1091-100
183. Tolhuis B, Palstra RJ, Splinter E, Grosveld F, de Laat W. 2002. Looping and interaction between hypersensitive sites in the active β-globin locus. Mol. Cell. 10:1453-65
184. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, et al. 2005. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310:644-48
185. Tompa M, Li N, Bailey TL, Church GM, De Moor B, et al. 2005. Assessing computational tools for the discovery of transcription factor binding sites. Nat. Biotechnol. 23:137-44
186. Vavouri T, Elgar G. 2005. Prediction of cis-regulatory elements using binding site matrices-the successes, the failures and the reasons for both. Curr. Opin. Genet. Dev. 15:395-402
187. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, et al. 2001. The sequence of the human genome. Science 291:1304-51
188. Vilar JM, Saiz L. 2005. DNA looping in gene regulation: from the assembly of macromolecular complexes to the control of transcriptional noise. Curr. Opin. Genet. Dev. 15:136-44
189. Vollrath D, Jaramillo-Babb VL, Clough MV, McIntosh I, Scott KM, et al. 1998. Loss-of-function mutations in the LIM-homeodomain gene, LMX1B, in nail-patella syndrome. Hum. Mol. Genet. 7:1091-98
190. Wagner T, Wirth J, Meyer J, Zabel B, Held M, et al. 1994. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79:1111-20
191. Wang HL, Wu T, Chang WT, Li AH, Chen MS, et al. 2000. Point mutation associated with X-linked dominant Charcot-Marie-Tooth disease impairs the P2 promoter activity of human connexin-32 gene. Brain. Res. Mol. Brain Res. 78:146-53
192. Wang X, Greenberg JF, Chamberlin HM. 2004. Evolution of regulatory elements producing a conserved gene expression pattern in Caenorhabditis. Evol. Dev. 6:237-45
193. Weinmann AS, Bartley SM, Zhang T, Zhang MQ, Farnham PJ. 2001. Use of chromatin immunoprecipitation to clone novel E2F target promoters. Mol. Cell. Biol. 21:6820-32
194. West AG, Fraser P. 2005. Remote control of gene transcription. Hum. Mol. Genet. 14(Spec. No. 1):R101-11
195. West AG, Gaszner M, Felsenfeld G. 2002. Insulators: many functions, many mechanisms. Genes Dev. 16:271-88
196. Wingender E, Dietze P, Karas H, Knuppel R. 1996. TRANSFAC: a database on transcription factors and their DNA binding sites. Nucleic Acids Res. 24:238-41
197. Woolfe A, Goodson M, Goode DK, Snell P, McEwen GK, et al. 2005. Highly conserved non-coding sequences are associated with vertebrate development. PLoS Biol. 3:e7
198. Yamashita R, Suzuki Y, Sugano S, Nakai K. 2005. Genome-wide analysis reveals strong correlation between CpG islands with nearby transcription start sites of genes and their tissue specificity. Gene 350:129-36
199. Yang WS, Nevin DN, Peng R, Brunzell JD, Deeb SS. 1995. Animation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity. Proc. Natl. Acad. Sci. USA 92:4462-66
200. Ashurst JL, Collins JE. 2003. Gene annotation: prediction and testing. Annu. Rev. Genomics Hum. Genet. 4:69-88
201. Gerasimova TI, Corces VG. 2001. Chromatin insulators and boundaries: effects on transcription and nuclear organization. Annu. Rev. Genet. 35:193-208
202. Lee TI, Young RA. 2000. Transcription of eukaryotic protein-coding genes. Annu. Rev. Genet. 34:77-137
203. Miller W, Makova KD, Nekrutenko A, Hardison RC. 2004. Comparative genomics. Annu. Rev. Genomics Hum. Genet. 5:15-56
204. Smale ST, Kadonaga JT. 2003. The RNA Polymerase II core promoter. Annu. Rev. Biochem. 72:449-79
205. Stone ER, Cooper GM, Sidow A. 2005. Trade-offs in detecting evolutionarily constrained sequence by comparative genomics. Annu. Rev. Genomics Hum. Genet. 6:143-64
206. AlignACE: http://atlas.med.harvard.edu/
207. DbTSS: http://dbtss.hgc.jp/
208. EPD: http://www.epd.isb-sib.ch/
209. FirstEF: http://rulai.cshl.org/tools/FirstEF/
210. FootPrinter: http://wingless.cs.washington.edu/htbin-post/unrestricted/ FootPrinterWeb/FootPrinterInput2.pl
211. JASPAR: http://jaspar.cgb.ki.se/cgi-bin/jaspar-db.pl
212. MEME: http://meme.sdsc.edu/meme/website/
213. PathoDB: http://www.gene-regulation.com/pub/databases.html#pathodb
214. PhastCons: http://www.cse.ucsc.edu/~acs/phastCons-HOWTO.html#paper
215. The ENCODE Project: http://www.genome.gov/ENCODE
216. TRANSFAC: http://www.gene-regulation.com/pub/databases.html#transfac